• Aug 26, 2026

  $49.35-1.14%

  Comparable Pharmaceutical Preparations companies rose 1.09% on average while GPCR fell 1.14%, a move not shared by the sector [1].

  • 1Peer group

• Aug 25, 2026

  $49.92+1.86%

  Comparable Pharmaceutical Preparations companies rose 2.31% on average, and GPCR rose alongside them [1].

  • 1Peer group

• Aug 24, 2026

  $49.01-0.16%

  Comparable Pharmaceutical Preparations companies fell 1.15% on average, and GPCR edged down in line with the sector [1].

  • 1Peer group

• Aug 21, 2026

  $49.09-2.83%

  Comparable Pharmaceutical Preparations companies rose 0.50% on average while GPCR fell 2.83%, a move not shared by the sector [1]. Seeking Alpha published an opinion piece arguing for the company's prospects for an oral GLP-1 approval, though opinion pieces are not reportable events [2].

  • 1Peer group
  • 2Seeking Alpha

• Aug 20, 2026

  $50.52-6.67%

  Comparable Pharmaceutical Preparations companies fell 2.48% on average on the day, and GPCR fell by a larger margin of 6.67%, with volume running at 2.6x its trailing average and the session spanning a range of 8.5% of the low [1][2].

  • 1Peer group
  • 2Market data

• Aug 19, 2026

  $54.13+1.12%

  Comparable Pharmaceutical Preparations companies rose 5.65% on average, and GPCR rose alongside them [1].

  • 1Peer group

• Aug 18, 2026

  $53.53-0.43%

Closing prices for GPCR. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.